BioPharma

Scaling Biopharma Manufacturing: Managing Pressure, Flow & Process Control The transition from laboratory-scale research to commercial-scale manufacturing represents one of the most challenging and critical phases in biopharmaceutical development. The complexity of scaling biopharma manufacturing extends far beyond simple volume...

Sustainable Fluid Management in Pharma: Reducing Energy & Resource Waste The pharmaceutical industry stands at a critical juncture where environmental stewardship and operational excellence must converge to create truly sustainable manufacturing practices. As global awareness of environmental challenges intensifies and...

Pressure Protection and Safety in Pharmaceutical Manufacturing Facilities The pharmaceutical manufacturing industry operates under some of the most stringent safety requirements of any industrial sector, with pressure protection pharma manufacturing systems serving as critical safeguards for personnel, equipment, and the...

Ensuring Sterility in Biopharma: Technologies for Contamination Control The pursuit of sterility in biopharmaceutical manufacturing represents one of the most critical challenges facing the industry today. As biologic therapies become increasingly complex and potent, the imperative to maintain absolute contamination...

The South Korean government has gone on to hold the Bio Innovation Roundtable at Songdo Convensia in Incheon as per the theme K-Bio: Accelerating Innovation. The Ministry of Food and Drug Safety, the Ministry of Economy and Finance, the...

Russia and Vietnam have gone on to officially formalize a major collaboration in healthcare, with Russia going ahead with the biopharma technology transfer to Vietnam. It is well to be noted that this agreement was officially concluded at a signing...

Symeres, a leading global Contract Research, Development and Manufacturing Organization (CRDMO), announces the acquisition of DGr Pharma, a drug development-focused consultancy, to expand its integrated early-stage drug development services and accelerate IND-enabling capabilities for biopharma clients. The acquisition is...